Terror groups hail Trump win

November 10, 2016

Washington, Nov 10: Islamic State and al-Qaeda jihadists have 'hailed' Donald Trump's win in presidential polls as the beginning of "dark times" for the US with some extremists predicting America's "demise" at the hands of the billionaire businessman, according to media reports.trumppp

Shortly after Trump was declared the victor, a number of prominent ideologues linked to jihadist outfits in the Middle East took to social media to cheer the prospect of a Trump presidency, The Washington Post reported.

Social-media sites associated with both the Islamic State and al-Qaeda hailed Trump's success as the beginning of "dark times" for the United States, marked by domestic unrest and new foreign military campaigns that would sap the strength of the American superpower, the report said.

"Rejoice...and find glad tidings in the imminent demise of America at the hands of Trump," Islamic State-affiliated Al-Minbar Jihadi Media network was quoted as saying.

The remarks of jihadists signaled their apparent belief that the victory of a candidate like Trump, who has suggested blocks on Muslim immigration and advocated torture, undermines the US' moral standing in the world.

"Trump's win of the American presidency will bring hostility of Muslims against America as a result of his reckless actions, which show the overt and hidden hatred against them," said an essay, provided by the SITE Intelligence group, a private organisation that monitors jihadists' web sites.

Rita Katz, director of the SITE Intelligence Group, on Twitter said, "AQ (al-Qaeda) & ISIS supporters on election: Trump exposes US' hatred of Muslims, will contribute to America/West's downfall -- likening to brexit."

She quoted pro-al-Qaeda accounts on social media as saying, "On 9-11, US struck with disaster at the hands of AQ (al-Qaeda). On 11-9, US struck with disaster at the hands of their own voters."

"Jihadists warn that Trump will unite the mujahideen; Announce: 'Bring it on, Donald'; 'The mujahideen are ready!'," another tweet by Katz said.

A pro-al-Qaeda al-Maqalaat Twitter account predicted that Trump would "make the US Enemy No.1 again," in the Muslim Middle East.

"Trump will serve as the perfect straw man for the next four years, like Bush did before him," it said.

Abu Muhammad al-Maqdisi, a jihadist ideologue linked to al-Qaeda, gloated about Trump's victory, suggesting that it "may be the beginning of America's fragmentation and the era of its breakup," according to the Post.

Just ahead of polls, the Islamic State terror group had called for "slaughter" of American voters on election day and urged Muslims not to participate in the democratic process.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 7,2020

Islamabad, May 7: Pakistan's COVID-19 cases have crossed 24,000 after 1,523 new infections were detected, while the death toll has jumped to 564 with 38 more people succumbing to the coronavirus, health officials said on Thursday.

Even as the country is seeing an increase in the number of coronavirus cases and fatalities, Prime Minister Imran Khan will discuss the easing of lockdown restrictions with his top aides on Thursday.

The Ministry of National Health Services said that out of the 24,073 total cases, Punjab reported 9,077, Sindh 8,640, Khyber-Pakhtunkhwa 3,712, Balochistan 1,495, Islamabad 521, Gilgit-Baltistan 388 and Pakistan-occupied Kashmir 76 cases.

After 38 more deaths on Wednesday, the total coronavirus patient death toll jumped to 564. Another 6,464 have recovered. A total of 1,523 new patients were added in a single day, the ministry.

So far, 244,778 tests have been conducted, including 12,196 in the last 24 hours, it said.

Prime Minister Khan will chair the National Coordination Committee (NCC) meeting on easing the lockdown restrictions in the country. The meeting will be attended by all chief ministers.

The issue was debated in the National Command and Operation Centre (NCOC) on Wednesday and in the Cabinet on Tuesday.

Planning Minister Asad Umar said that different proposals to allow certain businesses to open were prepared and will be presented before the Prime Minister for a final decision.

Earlier, Khan, undeterred by the mounting number of deaths and the new cases, announced that he was against a lockdown as it hits the poor people badly.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 9,2020

London, May 9: Air India's first evacuation flight from London will be taking off for Mumbai today.

The screening of passengers is underway.

"Air India's first evacuation flight from London taking off for Mumbai today at 1200. Flight is 100% booked! Shubh Yatra. Please stay in touch. GoI working to send more evacuation flights!" High Commission of India, London said in a tweet.

On Monday, India announced had that it will begin phased repatriation of its citizens stranded abroad from May 7.

The government said that Air India will operate 64 flights in the first week from May 7 to May 13 to bring back around 15,000 Indian nationals.

On day three of the 'Vande Bharat Mission', flights carrying Indians from the Gulf countries, the United Kingdom, Bangladesh and Malaysia will arrive in India.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.